ENO2 and neoplasm: Notably, hsa_circ_0041150 demonstrated superior diagnostic value for drug resistance compared to traditional lung cancer-related tumor markers such as CA125, CA211, and ProGRP in SCLC, albeit slightly weaker than NSE.